Your browser doesn't support javascript.
loading
How Did Breast Cancer Patients Fare during Different Phases of the COVID-19 Pandemic in Norway Compared to Age-Matched Controls?
Svendsen, Karianne; Leithe, Sigrid; Trewin-Nybråten, Cassia B; Balto, Aina; Nes, Lise Solberg; Meland, Anders; Børøsund, Elin; Kiserud, Cecilie E; Reinertsen, Kristin Valborg; Eriksen, Hege R; Gjelsvik, Ylva Maria; Ursin, Giske.
Afiliação
  • Svendsen K; Cancer Registry of Norway, Norwegian Institute of Public Health, 0379 Oslo, Norway.
  • Leithe S; Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, 0317 Oslo, Norway.
  • Trewin-Nybråten CB; The Lipid Clinic, Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, 0586 Oslo, Norway.
  • Balto A; Cancer Registry of Norway, Norwegian Institute of Public Health, 0379 Oslo, Norway.
  • Nes LS; Cancer Registry of Norway, Norwegian Institute of Public Health, 0379 Oslo, Norway.
  • Meland A; Cancer Registry of Norway, Norwegian Institute of Public Health, 0379 Oslo, Norway.
  • Børøsund E; Department of Digital Health Research, Division of Medicine, Oslo University Hospital, 0586 Oslo, Norway.
  • Kiserud CE; Department of Psychiatry and Psychology, Mayo Clinic College of Medicine and Science, Mayo Clinic, Rochester, MN 55905, USA.
  • Reinertsen KV; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318 Oslo, Norway.
  • Eriksen HR; Department of Social Sciences, Norwegian School of Sport Sciences, 0863 Oslo, Norway.
  • Gjelsvik YM; Department of Digital Health Research, Division of Medicine, Oslo University Hospital, 0586 Oslo, Norway.
  • Ursin G; Department of Nursing and Health Sciences, Faculty of Health and Social Sciences, University of South-Eastern Norway, 3054 Drammen, Norway.
Cancers (Basel) ; 16(3)2024 Jan 31.
Article em En | MEDLINE | ID: mdl-38339359
ABSTRACT
Little is known about how health-related quality of life (HRQoL) in breast cancer cases differed from that of controls during and after the COVID-19 pandemic. This study used data from an ongoing, nationwide HRQoL survey of 4279 newly diagnosed breast cancer cases and 2911 controls to investigate how breast cancer patients fared during different phases of the pandemic compared to controls. Responders during 2020-2022 were categorized into three COVID-19-related phases the social restrictions phase, the high infection rate phase, and the post-pandemic phase. Across phases, breast cancer cases had significantly worse scores in most HRQoL domains compared to controls. Apart from slightly more insomnia in the high infection rate phase for both cases and controls, and better social functioning for young cases in the post-COVID-19 phase, the case-control differences in HRQoL remained consistent across phases. When the phases were assessed as one period, young women and those living with children <18 years of age fared the worst among breast cancer cases, while single women fared the worst among controls. In contrast, controls living with children <18 years of age exhibited better HRQoL than controls without children. In summary, women with breast cancer did not appear to fare differently than controls in terms of HRQoL across COVID-19 phases. However, breast cancer cases with young children fared worse in their HRQoL than other breast cancer cases.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article